PCL was ranked among the top searched stocks for 4 days in the past month.


As of 2:31 PM on the 24th, PCL is trading at 40,100 KRW, up 3.22% from the previous day. This represents a 113.3% increase compared to August 27. PCL is known as a developer of in vitro diagnostic medical devices.

Over the past 5 days, individual investors have sold a net 9,992 shares, while foreigners and institutions have sold a net 15,443 shares and bought a net 23,604 shares, respectively.


On September 17, PCL became a market issue with the headline "Limit-up... COVID-19 diagnostic kit clinical trials underway in the U.S."


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing